"Immunization Schedule" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Schedule giving optimum times usually for primary and/or secondary immunization.
| Descriptor ID |
D007115
|
| MeSH Number(s) |
E02.095.465.425.400.470 E05.478.550.545
|
| Concept/Terms |
Immunization Schedule- Immunization Schedule
- Immunization Schedules
- Schedule, Immunization
- Schedules, Immunization
|
Below are MeSH descriptors whose meaning is more general than "Immunization Schedule".
Below are MeSH descriptors whose meaning is more specific than "Immunization Schedule".
This graph shows the total number of publications written about "Immunization Schedule" by people in this website by year, and whether "Immunization Schedule" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization Schedule" by people in Profiles.
-
Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics. Am J Prev Med. 2022 04; 62(4):538-547.
-
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021. MMWR Morb Mortal Wkly Rep. 2021 May 21; 70(20):753-758.
-
Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China. Pediatr Infect Dis J. 2019 11; 38(11):1150-1158.
-
Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice. Sci Rep. 2018 06 05; 8(1):8643.
-
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China. Pediatr Infect Dis J. 2016 09; 35(9):999-1010.
-
Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children. Am J Trop Med Hyg. 2016 06 01; 94(6):1348-1358.
-
Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial. Am J Trop Med Hyg. 2014 Jul; 91(1):119-28.
-
Communicating with parents about immunization safety: messages for pediatricians in the IOM report "the childhood immunization schedule and safety: stakeholder concerns, scientific evidence, and future studies". Acad Pediatr. 2013 Sep-Oct; 13(5):387-9.
-
Update on adult immunizations. J Am Board Fam Med. 2012 Jul-Aug; 25(4):496-510.
-
Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1637-41.